Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 05, 2024 10:35 ET
|
Acasti Pharma, Inc.
PRINCETON, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of...
Olon Continues its Growth Path and Announces a New Acquisition
September 04, 2024 05:00 ET
|
Olon SpA
MILAN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The acquisition plan involves a complete operational integration of Huvepharma Italia Srl and a plan to revive the production potential of the Garessio...
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
September 03, 2024 07:30 ET
|
23andMe, Inc.
Preliminary data from renal cancer and TMB-H/MSI-H cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presented Analysis of CD200 as an exploratory tissue-based biomarker associated with...
KFSHRC Concludes Participation at AMEE 2024 in Switzerland
August 29, 2024 02:56 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Concludes Participation at AMEE 2024 in Switzerland
KFSHRC Sets New Global Standards with VR Technology at AMEE 2024
August 22, 2024 11:17 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Sets New Global Standards with VR Technology at AMEE 2024
KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland
August 20, 2024 13:00 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland
Triyam Recognized on Inc. 5000 List for the Fourth Consecutive Year
August 15, 2024 09:00 ET
|
Access Information Management Shared Services, LLC
Company ranking leveled up 999 spots on this highlighted list of America’s Fastest-Growing Private Companies
Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
August 13, 2024 07:30 ET
|
Insignis Therapeutics, Inc.
Insignis’ liquid epinephrine sublingual spray for anaphylaxis, stable and usable under both extreme heat and cold, gains FDA Fast Track designation.
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
August 09, 2024 08:00 ET
|
Acasti Pharma, Inc.
Surpassed 50% Enrollment Milestone in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104Company Anticipates Completion of Patient Enrollment in the STRIVE-ON Trial in Late 2024 to Early 2025, with NDA...
[Latest] Global Bioplastics Packaging Market Size/Share Worth USD 51,357.1 Million by 2033 at a 12.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 01, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Bioplastics Packaging Market Size, Trends and Insights By Material (Polylactic...